Loading...
Header Logo
Keywords
Last Name
Institution

Robert Goldberg

Concepts (591)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Myocardial Infarction
121
2017
721
23.410
Why?
Hospitalization
81
2017
648
11.340
Why?
Heart Failure
50
2017
457
10.500
Why?
Hospital Mortality
60
2016
550
7.650
Why?
Acute Coronary Syndrome
23
2017
161
6.760
Why?
Aged
206
2018
7625
6.640
Why?
Massachusetts
84
2016
1451
5.490
Why?
Female
236
2018
18871
5.050
Why?
Male
221
2018
17061
5.030
Why?
Middle Aged
175
2018
9823
4.760
Why?
Aged, 80 and over
92
2017
2895
4.500
Why?
Humans
268
2018
33715
4.320
Why?
Venous Thromboembolism
16
2016
90
4.150
Why?
Stroke Volume
16
2015
198
4.110
Why?
Risk Factors
80
2017
3033
3.770
Why?
Angiotensin-Converting Enzyme Inhibitors
17
2017
101
3.130
Why?
Patient Discharge
16
2017
225
3.090
Why?
Retrospective Studies
54
2018
2640
2.930
Why?
Shock, Cardiogenic
11
2016
44
2.930
Why?
Cardiovascular Agents
11
2017
73
2.920
Why?
Prognosis
40
2016
910
2.890
Why?
Treatment Outcome
61
2018
2602
2.830
Why?
Incidence
42
2016
819
2.750
Why?
Time Factors
50
2017
2573
2.710
Why?
Risk Assessment
30
2015
1070
2.620
Why?
Age Factors
33
2016
1102
2.500
Why?
Electrocardiography
17
2015
293
2.450
Why?
Patient Readmission
8
2016
174
2.450
Why?
Inpatients
9
2016
152
2.420
Why?
Registries
35
2017
461
2.370
Why?
Atrial Fibrillation
9
2016
184
2.230
Why?
Diabetes Mellitus
8
2015
393
2.210
Why?
Adrenergic beta-Antagonists
15
2017
111
2.200
Why?
Emergency Medical Services
8
2016
127
2.160
Why?
Multivariate Analysis
32
2017
711
2.020
Why?
Coronary Artery Bypass
14
2015
255
2.000
Why?
Patient Acceptance of Health Care
9
2013
264
1.990
Why?
Ventricular Function, Left
9
2015
145
1.920
Why?
Acute Disease
28
2015
523
1.860
Why?
Follow-Up Studies
28
2016
1520
1.830
Why?
Sex Factors
23
2015
661
1.820
Why?
Coronary Disease
12
2014
338
1.810
Why?
Population Surveillance
10
2015
185
1.790
Why?
Survival Rate
18
2015
491
1.760
Why?
Length of Stay
12
2017
402
1.740
Why?
Odds Ratio
26
2016
632
1.730
Why?
Logistic Models
27
2016
906
1.720
Why?
Research Design
9
2014
377
1.720
Why?
Venous Thrombosis
6
2014
89
1.710
Why?
Diabetes, Gestational
4
2015
86
1.600
Why?
Prospective Studies
25
2015
1657
1.580
Why?
Glucose Tolerance Test
3
2013
78
1.580
Why?
Residence Characteristics
7
2013
165
1.570
Why?
Disease Management
6
2015
115
1.520
Why?
Comorbidity
25
2015
721
1.510
Why?
Cardiovascular Diseases
8
2016
512
1.490
Why?
Adult
56
2018
9731
1.460
Why?
Diabetes Complications
5
2014
90
1.450
Why?
Angina, Unstable
13
2009
66
1.410
Why?
Graves Ophthalmopathy
2
2018
5
1.360
Why?
Decompression, Surgical
2
2018
20
1.350
Why?
Nutrition Surveys
4
2017
100
1.280
Why?
Chi-Square Distribution
15
2017
362
1.270
Why?
Patient Selection
5
2017
283
1.250
Why?
Healthcare Disparities
4
2017
133
1.240
Why?
Myocardial Revascularization
7
2014
58
1.210
Why?
Glomerular Filtration Rate
6
2013
55
1.210
Why?
Fibrinolytic Agents
9
2012
130
1.190
Why?
Cross-Sectional Studies
18
2018
1218
1.180
Why?
Health Education
2
2016
174
1.170
Why?
Thrombolytic Therapy
11
2011
122
1.170
Why?
Oculomotor Muscles
3
2018
7
1.160
Why?
Hemorrhage
9
2014
154
1.150
Why?
Survival Analysis
18
2014
375
1.150
Why?
Anticoagulants
7
2014
209
1.130
Why?
Diagnostic Imaging
3
2014
169
1.120
Why?
Clinical Trials as Topic
4
2014
295
1.120
Why?
Pulmonary Embolism
7
2014
125
1.110
Why?
Kidney Diseases
4
2010
105
1.110
Why?
Urban Population
5
2015
163
1.110
Why?
Outcome Assessment (Health Care)
11
2014
386
1.090
Why?
Pulmonary Disease, Chronic Obstructive
3
2015
106
1.090
Why?
Brain Injuries
2
2015
82
1.080
Why?
Heart Block
3
2009
19
1.060
Why?
Drug Utilization
5
2017
149
1.020
Why?
Randomized Controlled Trials as Topic
7
2017
335
1.010
Why?
Intensive Care Units
2
2015
209
1.000
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
9
2014
144
0.980
Why?
Blood Glucose
4
2014
371
0.970
Why?
United States
32
2017
4047
0.960
Why?
Hyperglycemia
3
2014
79
0.950
Why?
Proportional Hazards Models
15
2014
457
0.940
Why?
Body Weight
2
2014
345
0.940
Why?
Stroke
10
2013
471
0.920
Why?
Continental Population Groups
3
2017
131
0.900
Why?
Secondary Prevention
6
2015
88
0.890
Why?
Ambulances
2
2012
20
0.880
Why?
Transportation of Patients
3
2009
18
0.880
Why?
Prevalence
16
2017
813
0.880
Why?
Platelet Aggregation Inhibitors
8
2014
176
0.880
Why?
Circadian Rhythm
2
2013
264
0.880
Why?
Sample Size
2
2017
39
0.870
Why?
Cohort Studies
17
2018
1435
0.860
Why?
Coronary Artery Disease
7
2014
228
0.840
Why?
Survivors
3
2017
85
0.840
Why?
Ethnic Groups
4
2017
223
0.840
Why?
Diuretics
3
2015
32
0.830
Why?
Echocardiography
3
2009
206
0.830
Why?
Central Nervous System Stimulants
2
2012
60
0.830
Why?
Myocardial Reperfusion
4
2010
33
0.820
Why?
Ventricular Dysfunction, Left
5
2013
89
0.820
Why?
Health Knowledge, Attitudes, Practice
4
2016
581
0.810
Why?
Resuscitation Orders
3
2008
13
0.810
Why?
Primary Prevention
4
2014
94
0.800
Why?
Longitudinal Studies
11
2017
695
0.790
Why?
Aspirin
10
2014
137
0.780
Why?
Decision Support Techniques
4
2015
93
0.780
Why?
Mortality
5
2012
83
0.770
Why?
Anemia
2
2011
59
0.770
Why?
Hypertension
4
2016
365
0.770
Why?
Data Collection
5
2016
354
0.760
Why?
Recurrence
9
2016
396
0.750
Why?
Case-Control Studies
9
2014
654
0.740
Why?
Sex Distribution
11
2014
212
0.740
Why?
Meta-Analysis as Topic
2
2015
59
0.730
Why?
Aging
4
2012
513
0.710
Why?
Hospital Administration
2
2014
42
0.710
Why?
Awareness
2
2016
56
0.700
Why?
Medication Adherence
2
2017
155
0.700
Why?
Cardiotonic Agents
2
2015
34
0.690
Why?
Predictive Value of Tests
14
2015
677
0.690
Why?
Medicare
4
2015
232
0.680
Why?
Feeding Behavior
4
2015
248
0.670
Why?
Delayed Diagnosis
1
2016
20
0.670
Why?
Age Distribution
11
2014
222
0.660
Why?
Calcium Channel Blockers
2
2015
50
0.650
Why?
Lung Diseases
2
2017
112
0.650
Why?
Prosthesis Implantation
2
2015
16
0.650
Why?
Body Mass Index
4
2014
709
0.640
Why?
Diabetes Mellitus, Type 2
2
2011
424
0.640
Why?
Review Literature as Topic
1
2015
31
0.640
Why?
Weight Loss
2
2014
201
0.640
Why?
School Health Services
1
2016
34
0.640
Why?
Clinical Protocols
1
2016
87
0.630
Why?
Rural Population
1
2016
85
0.630
Why?
Artificial Organs
1
2015
1
0.620
Why?
Eyelid Diseases
1
2015
2
0.620
Why?
Corneal Diseases
1
2015
3
0.620
Why?
Conjunctival Diseases
1
2015
3
0.620
Why?
Stevens-Johnson Syndrome
1
2015
3
0.610
Why?
Cause of Death
7
2014
117
0.610
Why?
Critical Care
3
2015
165
0.600
Why?
Urban Health
3
2015
47
0.600
Why?
Orbit
1
2014
11
0.600
Why?
Vision Disorders
1
2015
26
0.600
Why?
Life Style
4
2015
262
0.600
Why?
Students
1
2016
124
0.600
Why?
Evidence-Based Medicine
5
2010
280
0.580
Why?
Decision Making
2
2015
204
0.580
Why?
Temperament
1
2014
13
0.570
Why?
Endpoint Determination
1
2014
21
0.570
Why?
Forecasting
2
2014
156
0.570
Why?
Perception
1
2014
86
0.570
Why?
Anger
1
2014
24
0.570
Why?
Cross-Over Studies
2
2013
95
0.560
Why?
Outcome and Process Assessment (Health Care)
4
2012
177
0.550
Why?
Biomedical Research
2
2013
141
0.550
Why?
Drug Prescriptions
3
2010
120
0.550
Why?
Quality of Life
5
2017
419
0.550
Why?
Thinness
2
2011
23
0.550
Why?
Sex Characteristics
1
2014
132
0.550
Why?
Warfarin
1
2014
78
0.540
Why?
Glucose Intolerance
1
2013
61
0.530
Why?
Databases, Factual
7
2015
417
0.520
Why?
Medical Records
6
2013
129
0.520
Why?
Health Promotion
3
2012
360
0.510
Why?
Parents
1
2014
183
0.510
Why?
Chest Pain
6
2012
40
0.510
Why?
Outpatients
2
2015
61
0.500
Why?
Tobacco
1
2012
63
0.500
Why?
Prisons
1
2012
59
0.500
Why?
Smoking
3
2012
737
0.490
Why?
Leg
1
2012
71
0.490
Why?
Metabolic Syndrome X
3
2011
103
0.490
Why?
Ventricular Fibrillation
2
2008
30
0.490
Why?
Heart Failure, Systolic
2
2011
11
0.470
Why?
Heart Failure, Diastolic
2
2011
9
0.470
Why?
Heart Rate
5
2012
220
0.470
Why?
Hospitals, Community
2
2009
47
0.470
Why?
Vietnam
3
2016
56
0.450
Why?
Attention Deficit Disorder with Hyperactivity
1
2012
154
0.450
Why?
Obesity
4
2011
871
0.440
Why?
Drug Utilization Review
2
2007
53
0.440
Why?
Anticholesteremic Agents
2
2008
32
0.440
Why?
Severity of Illness Index
9
2015
860
0.440
Why?
Peripheral Vascular Diseases
2
2007
37
0.430
Why?
Overweight
3
2014
177
0.420
Why?
Angiocardiography
1
2009
6
0.420
Why?
Myocardial Ischemia
6
2007
108
0.420
Why?
Gated Blood-Pool Imaging
1
2009
12
0.420
Why?
Quality of Health Care
3
2010
354
0.410
Why?
Algorithms
6
2012
640
0.410
Why?
Lupus Erythematosus, Systemic
1
2009
73
0.410
Why?
Smoking Cessation
1
2012
386
0.400
Why?
Antihypertensive Agents
1
2010
110
0.400
Why?
Heart Atria
1
2009
71
0.400
Why?
Blepharoptosis
2
2018
2
0.390
Why?
Health Services for the Aged
1
2008
37
0.390
Why?
Gastric Bypass
1
2009
59
0.390
Why?
Video-Assisted Surgery
1
2008
7
0.390
Why?
Obesity, Morbid
1
2009
59
0.390
Why?
Models, Anatomic
1
2008
34
0.380
Why?
Bronchoscopy
1
2008
38
0.380
Why?
Women's Health
4
2007
302
0.380
Why?
Blood Pressure
4
2012
367
0.380
Why?
Models, Biological
1
2013
954
0.380
Why?
Postoperative Complications
4
2014
611
0.370
Why?
Biopsy, Needle
1
2008
105
0.370
Why?
Kidney
2
2013
262
0.370
Why?
Causality
1
2007
41
0.360
Why?
Angina Pectoris
2
2004
44
0.360
Why?
Confidence Intervals
5
2015
250
0.360
Why?
Analysis of Variance
8
2018
535
0.360
Why?
Poverty Areas
2
2013
11
0.350
Why?
Socioeconomic Factors
5
2015
594
0.350
Why?
Hyperlipidemias
1
2007
48
0.350
Why?
Thromboembolism
2
2006
41
0.350
Why?
Arthralgia
1
2007
32
0.350
Why?
Fatty Acids, Omega-3
1
2007
29
0.340
Why?
Time
2
2008
22
0.340
Why?
Europe
7
2013
115
0.330
Why?
Pregnancy
4
2015
1238
0.320
Why?
Sexuality
2
2002
23
0.320
Why?
Renal Insufficiency, Chronic
2
2017
35
0.310
Why?
Health Status
4
2017
314
0.310
Why?
Disease Progression
4
2015
473
0.310
Why?
Cost-Benefit Analysis
3
2016
172
0.310
Why?
Dietary Supplements
1
2007
157
0.310
Why?
Medical History Taking
2
2002
46
0.310
Why?
September 11 Terrorist Attacks
1
2005
18
0.300
Why?
Drug Therapy, Combination
7
2010
316
0.300
Why?
Physicians
1
2007
216
0.290
Why?
Respiration Disorders
1
2004
14
0.290
Why?
C-Reactive Protein
1
2005
147
0.290
Why?
Leukocytosis
1
2003
7
0.280
Why?
Defibrillators, Implantable
2
2015
51
0.280
Why?
Attitude of Health Personnel
1
2007
371
0.280
Why?
Blepharoplasty
2
2018
4
0.270
Why?
Inflammation
2
2007
626
0.270
Why?
South America
4
2013
24
0.270
Why?
Young Adult
8
2015
2216
0.270
Why?
Demography
6
2014
156
0.270
Why?
Heart Arrest
3
2012
68
0.270
Why?
North America
4
2013
82
0.270
Why?
Tendinopathy
2
2014
4
0.260
Why?
Hospitals, Urban
2
2015
43
0.260
Why?
Regression Analysis
7
2014
430
0.260
Why?
Hospitals, Teaching
2
2015
87
0.260
Why?
Syndrome
11
2007
119
0.250
Why?
Heart Conduction System
1
2002
27
0.250
Why?
Phosphodiesterase Inhibitors
1
2002
19
0.250
Why?
Erectile Dysfunction
1
2002
15
0.250
Why?
Aortic Aneurysm, Abdominal
2
2014
91
0.250
Why?
Hypotension
2
2013
32
0.250
Why?
Validation Studies as Topic
2
2012
19
0.250
Why?
Eyelids
2
2018
5
0.250
Why?
Adolescent
7
2016
4050
0.240
Why?
Mass Screening
1
2005
344
0.240
Why?
Blood Vessel Prosthesis Implantation
2
2014
119
0.240
Why?
Cardiology
1
2002
52
0.240
Why?
Community Health Services
3
2012
100
0.240
Why?
Ambulatory Care Facilities
1
2002
72
0.240
Why?
Continuity of Patient Care
3
2014
119
0.240
Why?
Academic Medical Centers
2
2015
167
0.230
Why?
Piperazines
1
2002
93
0.230
Why?
Occupational Diseases
2
2014
226
0.220
Why?
Attitude to Health
1
2002
257
0.220
Why?
Hispanic Americans
1
2004
401
0.220
Why?
Renal Insufficiency
2
2012
41
0.220
Why?
Models, Cardiovascular
2
2011
53
0.220
Why?
Insurance Claim Review
3
2015
52
0.220
Why?
Adipose Tissue
2
2011
222
0.210
Why?
Homeless Persons
3
2006
64
0.200
Why?
Hematocrit
2
2011
36
0.200
Why?
New Zealand
4
2013
27
0.200
Why?
Australia
4
2013
49
0.200
Why?
Air Pollutants
2
2009
44
0.190
Why?
Poverty
3
2006
217
0.190
Why?
Quality Assurance, Health Care
2
2012
214
0.190
Why?
Cost of Illness
2
2015
96
0.180
Why?
Disease-Free Survival
1
2017
126
0.180
Why?
Interviews as Topic
2
2013
331
0.180
Why?
Patient Compliance
2
2014
291
0.180
Why?
Workplace
2
2011
117
0.180
Why?
Pilot Projects
3
2014
499
0.180
Why?
Reproducibility of Results
4
2015
995
0.180
Why?
Guideline Adherence
3
2013
214
0.180
Why?
Electronic Health Records
2
2015
123
0.170
Why?
Drug Administration Schedule
2
2014
216
0.170
Why?
Hospitals
2
2012
167
0.170
Why?
Geriatric Assessment
2
2014
87
0.170
Why?
Patient Education as Topic
4
2007
387
0.170
Why?
India
1
2016
46
0.160
Why?
Health Facility Size
1
2015
17
0.160
Why?
Hospitals, Rural
1
2015
19
0.160
Why?
Neoplasms
2
2013
586
0.160
Why?
Culture
1
2016
63
0.160
Why?
Georgia
1
2015
31
0.160
Why?
Practice Guidelines as Topic
3
2013
435
0.160
Why?
Genotype
2
2014
459
0.160
Why?
Ophthalmologic Surgical Procedures
1
2015
5
0.150
Why?
Data Interpretation, Statistical
1
2016
167
0.150
Why?
Stearoyl-CoA Desaturase
2
2011
6
0.150
Why?
Fertility
1
2015
47
0.150
Why?
Diplopia
1
2014
5
0.150
Why?
Visual Fields
1
2014
12
0.150
Why?
Cholesterol, LDL
2
2007
102
0.150
Why?
Executive Function
1
2014
24
0.150
Why?
Memory Disorders
1
2014
31
0.150
Why?
Health Care Surveys
3
2010
234
0.150
Why?
Aortic Rupture
1
2014
35
0.150
Why?
Mental Recall
1
2015
112
0.150
Why?
Chronic Disease
3
2017
530
0.150
Why?
Heart Ventricles
2
2007
135
0.150
Why?
Patient Admission
1
2014
97
0.150
Why?
Artificial Intelligence
1
2014
57
0.150
Why?
Reoperation
1
2014
144
0.150
Why?
Death, Sudden, Cardiac
2
2012
37
0.150
Why?
Information Storage and Retrieval
1
2014
62
0.140
Why?
Proto-Oncogene Proteins c-fyn
1
2014
6
0.140
Why?
Chromosomes, Human, Pair 6
1
2014
15
0.140
Why?
Hostility
1
2014
15
0.140
Why?
Wrist
1
2014
15
0.140
Why?
Surgical Flaps
1
2015
72
0.140
Why?
Self Concept
1
2014
90
0.140
Why?
Menopause
2
2007
138
0.140
Why?
Postpartum Period
1
2014
77
0.140
Why?
Eye Movements
1
2014
63
0.140
Why?
False Negative Reactions
1
2013
33
0.140
Why?
Epidemiologic Research Design
1
2013
8
0.140
Why?
Up-Regulation
1
2014
298
0.140
Why?
Morbidity
1
2013
49
0.140
Why?
Leukocyte Count
2
2004
82
0.140
Why?
Sensitivity and Specificity
3
2012
784
0.140
Why?
Comparative Effectiveness Research
1
2013
22
0.140
Why?
Psychomotor Performance
1
2014
128
0.140
Why?
Brain Ischemia
2
2013
168
0.140
Why?
Brain Hemorrhage, Traumatic
1
2013
5
0.140
Why?
Sleep
1
2014
83
0.140
Why?
Clinical Laboratory Techniques
1
2013
36
0.140
Why?
Glasgow Coma Scale
1
2013
17
0.140
Why?
Aggression
1
2014
67
0.140
Why?
Encephalocele
1
2013
10
0.140
Why?
Posture
1
2014
102
0.140
Why?
Brain Edema
1
2013
18
0.140
Why?
Diet
2
2015
456
0.140
Why?
Systemic Inflammatory Response Syndrome
1
2013
19
0.140
Why?
Injury Severity Score
1
2013
49
0.140
Why?
Cold Temperature
1
2013
30
0.140
Why?
Ambulatory Care
2
2006
206
0.130
Why?
Quality Indicators, Health Care
2
2012
247
0.130
Why?
Fever
1
2013
57
0.130
Why?
Weight Gain
1
2014
151
0.130
Why?
Genome-Wide Association Study
1
2014
161
0.130
Why?
Asthma
1
2015
289
0.130
Why?
Digestive System Diseases
1
2013
12
0.130
Why?
Cognition Disorders
1
2014
171
0.130
Why?
International Cooperation
2
2004
56
0.130
Why?
Hot Temperature
1
2013
88
0.130
Why?
Urinary Tract Infections
1
2013
40
0.130
Why?
Angiotensin II Type 1 Receptor Blockers
2
2010
22
0.130
Why?
Health Services Accessibility
3
2006
297
0.130
Why?
Ticlopidine
2
2011
57
0.130
Why?
Calcium Signaling
1
2014
133
0.130
Why?
Electric Countershock
1
2012
28
0.130
Why?
Tachycardia
1
2012
24
0.130
Why?
Cross Infection
1
2013
85
0.130
Why?
International Classification of Diseases
4
2014
85
0.130
Why?
Homeostasis
1
2014
218
0.130
Why?
Consensus
1
2012
47
0.130
Why?
Middle East
1
2011
5
0.120
Why?
Particle Size
1
2012
242
0.120
Why?
Terminology as Topic
1
2012
97
0.120
Why?
Angioplasty
1
2011
27
0.120
Why?
Ischemic Attack, Transient
1
2012
47
0.120
Why?
Child
3
2014
2699
0.120
Why?
Health Behavior
2
2013
376
0.120
Why?
Wrist Injuries
1
2011
9
0.120
Why?
Platelet Glycoprotein GPIIb-IIIa Complex
3
2007
49
0.120
Why?
Probability
2
2008
146
0.120
Why?
Fatty Acids, Monounsaturated
1
2010
13
0.120
Why?
Awards and Prizes
1
2011
16
0.120
Why?
Women
1
2011
36
0.110
Why?
Vehicle Emissions
2
2009
20
0.110
Why?
Vena Cava Filters
1
2010
15
0.110
Why?
Environmental Exposure
2
2009
122
0.110
Why?
Creatinine
1
2010
85
0.110
Why?
Atherosclerosis
1
2011
112
0.110
Why?
Double-Blind Method
2
2009
472
0.110
Why?
Publishing
1
2011
52
0.110
Why?
Sepsis
1
2012
142
0.110
Why?
Edema
1
2010
32
0.110
Why?
New England
1
2010
195
0.110
Why?
Depression
1
2014
406
0.110
Why?
Infection
1
2010
58
0.110
Why?
Coronary Angiography
1
2010
146
0.110
Why?
Dyspnea
1
2010
43
0.110
Why?
Sodium, Dietary
1
2009
15
0.110
Why?
Australasia
2
2013
6
0.110
Why?
Glucose
1
2012
312
0.110
Why?
Metoprolol
1
2009
8
0.110
Why?
Motor Activity
1
2013
305
0.110
Why?
Polymorphism, Single Nucleotide
1
2011
303
0.110
Why?
Boston
2
2012
211
0.110
Why?
Catheterization, Swan-Ganz
1
2009
13
0.110
Why?
Carbon
1
2009
24
0.100
Why?
Insulin Resistance
1
2012
298
0.100
Why?
Computer Simulation
1
2011
306
0.100
Why?
Patient Participation
2
2007
82
0.100
Why?
Cholesterol
3
2005
219
0.100
Why?
Dose-Response Relationship, Drug
2
2009
651
0.100
Why?
Cough
1
2010
123
0.100
Why?
Heparin
2
2007
96
0.100
Why?
Mucormycosis
1
2008
3
0.100
Why?
Echinocandins
1
2008
4
0.100
Why?
Orbital Diseases
1
2008
9
0.100
Why?
Tachycardia, Ventricular
1
2008
21
0.100
Why?
Rhinitis
1
2008
11
0.100
Why?
Amphotericin B
1
2008
18
0.100
Why?
Consumer Satisfaction
1
2008
1
0.100
Why?
Polyvinyl Chloride
1
2008
2
0.100
Why?
Adaptation, Psychological
1
2009
160
0.100
Why?
Audiovisual Aids
1
2008
8
0.100
Why?
Air Pollution
1
2008
11
0.100
Why?
Sus scrofa
1
2008
26
0.100
Why?
Motor Vehicles
1
2008
14
0.100
Why?
Pulmonary Medicine
1
2008
12
0.100
Why?
Trachea
1
2008
54
0.090
Why?
Bronchi
1
2008
63
0.090
Why?
Antifungal Agents
1
2008
79
0.090
Why?
Drug Information Services
1
2007
6
0.090
Why?
Angioplasty, Balloon
1
2008
38
0.090
Why?
Mental Disorders
1
2013
467
0.090
Why?
Equipment Design
1
2008
221
0.090
Why?
Mass Media
1
2007
23
0.090
Why?
Upper Extremity
1
2007
27
0.090
Why?
Costa Rica
3
2013
3
0.090
Why?
Enoxaparin
1
2007
12
0.090
Why?
Patient Transfer
2
2010
36
0.090
Why?
Decision Support Systems, Clinical
1
2007
47
0.090
Why?
Life Tables
1
2007
24
0.090
Why?
Canada
3
2014
68
0.090
Why?
Evaluation Studies as Topic
1
2007
104
0.090
Why?
Heparin, Low-Molecular-Weight
1
2007
23
0.090
Why?
User-Computer Interface
1
2007
106
0.090
Why?
Delivery of Health Care
1
2009
166
0.090
Why?
Critical Illness
1
2008
141
0.090
Why?
Life Expectancy
2
2005
18
0.080
Why?
Drug Therapy
1
2006
49
0.080
Why?
Arteries
1
2006
43
0.080
Why?
Pain Measurement
1
2007
202
0.080
Why?
Internal Medicine
1
2007
138
0.080
Why?
Spironolactone
1
2005
5
0.080
Why?
Family Practice
1
2007
174
0.080
Why?
District of Columbia
1
2005
11
0.080
Why?
Education
1
2005
45
0.080
Why?
Disease Susceptibility
1
2005
99
0.080
Why?
Health Services Research
3
2012
215
0.080
Why?
New York City
1
2005
66
0.080
Why?
Signal Transduction
1
2014
2210
0.080
Why?
Occupational Health Services
1
2005
43
0.070
Why?
Medicare Part B
1
2004
5
0.070
Why?
Stents
2
2004
193
0.070
Why?
Hunger
1
2004
14
0.070
Why?
Diagnostic Techniques, Cardiovascular
1
2003
5
0.070
Why?
Transportation
1
2004
23
0.070
Why?
Occupational Health
1
2005
121
0.070
Why?
Housing
1
2004
31
0.070
Why?
Internet
1
2007
363
0.070
Why?
Heart Diseases
1
2005
140
0.070
Why?
Triglycerides
1
2005
194
0.070
Why?
Cardiac Output, Low
1
2003
9
0.070
Why?
Food Supply
1
2004
38
0.070
Why?
Arrhythmias, Cardiac
1
2004
69
0.070
Why?
Qualitative Research
1
2004
179
0.070
Why?
Nursing Homes
1
2006
287
0.070
Why?
Mothers
1
2004
101
0.070
Why?
Markov Chains
1
2002
23
0.060
Why?
Primary Health Care
1
2007
402
0.060
Why?
Anticarcinogenic Agents
1
2002
16
0.060
Why?
Exercise Test
1
2003
156
0.060
Why?
Tamoxifen
1
2002
30
0.060
Why?
Echocardiography, Doppler
1
2003
83
0.060
Why?
Endometrial Neoplasms
1
2002
30
0.060
Why?
Patient-Centered Care
1
2004
123
0.060
Why?
Blood Coagulation
1
2002
29
0.060
Why?
United States Food and Drug Administration
2
2012
41
0.060
Why?
Physical Examination
2
2014
81
0.060
Why?
Sulfones
1
2002
23
0.060
Why?
Multicenter Studies as Topic
1
2002
48
0.060
Why?
Purines
1
2002
26
0.060
Why?
Self Disclosure
1
2002
41
0.060
Why?
Vaginal Smears
1
2002
75
0.060
Why?
Hypercholesterolemia
1
2002
63
0.060
Why?
European Continental Ancestry Group
1
2004
438
0.060
Why?
Postmenopause
1
2002
214
0.060
Why?
Emergency Service, Hospital
1
2006
396
0.060
Why?
Hemoglobin A, Glycosylated
1
2002
126
0.060
Why?
Exercise
1
2005
517
0.060
Why?
Physician-Patient Relations
1
2002
280
0.050
Why?
Peptides
1
2002
400
0.050
Why?
Animals
2
2011
14079
0.040
Why?
Breast Neoplasms
1
2002
698
0.040
Why?
Bronchodilator Agents
1
2015
52
0.040
Why?
Epidemiologic Methods
2
2006
68
0.040
Why?
Glucocorticoids
1
2015
95
0.040
Why?
Internationality
1
2014
28
0.040
Why?
Medical Records, Problem-Oriented
1
2014
8
0.040
Why?
Diagnosis, Differential
2
2007
638
0.040
Why?
Interview, Psychological
1
2014
61
0.040
Why?
Emergencies
1
2014
69
0.040
Why?
Poisson Distribution
1
2014
41
0.040
Why?
Linear Models
1
2015
339
0.040
Why?
Respiration, Artificial
1
2015
168
0.040
Why?
Occupations
1
2014
45
0.040
Why?
Propensity Score
1
2014
69
0.040
Why?
Video Recording
1
2014
68
0.040
Why?
Neuropsychological Tests
1
2014
223
0.030
Why?
Administration, Oral
1
2014
199
0.030
Why?
Proteinuria
1
2013
19
0.030
Why?
History, Ancient
1
2013
9
0.030
Why?
Puerto Rico
1
2012
109
0.030
Why?
Area Under Curve
1
2012
76
0.030
Why?
alpha-Linolenic Acid
1
2011
4
0.030
Why?
Surgical Procedures, Operative
1
2012
78
0.030
Why?
Confidentiality
1
2012
40
0.030
Why?
Haplotypes
1
2011
99
0.030
Why?
Societies, Medical
1
2012
142
0.030
Why?
Aorta, Abdominal
1
2011
38
0.030
Why?
San Francisco
1
2011
9
0.030
Why?
Iliac Artery
1
2011
33
0.030
Why?
Pneumonia
1
2012
158
0.030
Why?
Fatty Acids
1
2011
134
0.030
Why?
Alleles
1
2011
304
0.030
Why?
Samoa
1
2009
1
0.030
Why?
Nomograms
1
2009
7
0.030
Why?
Lipopeptides
1
2008
16
0.020
Why?
Diet Surveys
1
2008
63
0.020
Why?
Dietary Fats
1
2009
201
0.020
Why?
Energy Intake
1
2009
210
0.020
Why?
Kidney Function Tests
1
2007
20
0.020
Why?
Dissent and Disputes
1
2007
3
0.020
Why?
Aftercare
1
2007
21
0.020
Why?
Liver
1
2010
536
0.020
Why?
Lower Extremity
1
2007
57
0.020
Why?
Catheterization, Central Venous
1
2007
67
0.020
Why?
Statistics, Nonparametric
1
2007
169
0.020
Why?
Ultrasonography
1
2007
293
0.020
Why?
Renal Dialysis
1
2007
142
0.020
Why?
Triage
1
2006
52
0.020
Why?
Vulnerable Populations
1
2006
55
0.020
Why?
Gene Expression Regulation
1
2011
1187
0.020
Why?
Epidemiologic Studies
1
2005
34
0.020
Why?
Quality-Adjusted Life Years
1
2005
21
0.020
Why?
Pyridines
1
2005
79
0.020
Why?
Drug Costs
1
2005
41
0.020
Why?
Americas
1
2004
6
0.020
Why?
Withholding Treatment
1
2004
21
0.020
Why?
Child, Preschool
1
2008
1318
0.020
Why?
Streptokinase
1
2004
6
0.020
Why?
Centers for Medicare and Medicaid Services (U.S.)
1
2004
33
0.020
Why?
Emergency Medical Service Communication Systems
1
2004
3
0.020
Why?
Time and Motion Studies
1
2004
8
0.020
Why?
Health Care Costs
1
2005
110
0.020
Why?
Public Assistance
1
2004
11
0.020
Why?
Resuscitation
1
2004
39
0.020
Why?
Mother-Child Relations
1
2004
25
0.020
Why?
Developing Countries
1
2003
46
0.020
Why?
Parenting
1
2004
51
0.020
Why?
Child Welfare
1
2004
47
0.020
Why?
Argentina
1
2002
2
0.020
Why?
Brazil
1
2002
42
0.020
Why?
Diastole
1
2003
75
0.020
Why?
Blood Coagulation Tests
1
2002
5
0.020
Why?
Thrombophilia
1
2002
12
0.020
Why?
Hysterectomy
1
2002
48
0.020
Why?
Family Characteristics
1
2002
36
0.020
Why?
Insurance, Health
1
2002
81
0.020
Why?
Uterine Cervical Neoplasms
1
2002
133
0.010
Why?
Software
1
2003
242
0.010
Why?
Patient Satisfaction
1
2003
271
0.010
Why?
Goldberg's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_